stella
beta
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas — Stella
Recruiting
Back to Solid Tumor trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(6 sites)
United States
Northwell Health Cancer Institute, Lake Success, New York
NEXT Houston, Houston, Texas
NEXT Dallas, Irving, Texas
NEXT Oncology, San Antonio, Texas
The START Center, San Antonio, Texas
Show all 6 locations
View full record on ClinicalTrials.gov